Goldman Sachs Group restated their neutral rating on shares of Smiths Group (LON:SMIN) in a report issued on Wednesday morning, ThisIsMoney.Co.Uk reports.
Several other research firms have also recently weighed in on SMIN. Credit Suisse Group initiated coverage on Yunji in a report on Wednesday, July 3rd. They set an outperform rating and a $14.50 price target on the stock. Liberum Capital set a C$2.20 price target on Millennial Lithium and gave the stock a buy rating in a report on Friday, June 7th. Citigroup restated a sell rating on shares of Bayerische Motoren Werke in a report on Friday, April 5th. Deutsche Bank restated a buy rating and set a $18.00 price target on shares of STMicroelectronics in a report on Monday, April 15th. Finally, JPMorgan Chase & Co. set a €21.00 ($24.42) price target on Signify and gave the stock a sell rating in a report on Monday, March 25th. Two analysts have rated the stock with a sell rating, six have assigned a hold rating and four have issued a buy rating to the stock. Smiths Group currently has an average rating of Hold and an average price target of GBX 1,611 ($21.05).
Shares of LON:SMIN traded up GBX 9.50 ($0.12) during midday trading on Wednesday, hitting GBX 1,574.50 ($20.57). 533,991 shares of the stock were exchanged, compared to its average volume of 1,190,000. The firm has a market cap of $6.23 billion and a PE ratio of 21.54. The company has a debt-to-equity ratio of 65.38, a current ratio of 2.36 and a quick ratio of 1.66. The business’s 50-day simple moving average is GBX 1,516.48. Smiths Group has a 12 month low of GBX 1,257 ($16.42) and a 12 month high of GBX 1,753 ($22.91).
About Smiths Group
Smiths Group plc operates as a technology company severing the medical technology, security and defense, general industrial, oil and gas, and space and commercial aerospace markets worldwide. The company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect, and Flex-Tek.
See Also: How is a price target determined?
Receive News & Ratings for Smiths Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group and related companies with MarketBeat.com's FREE daily email newsletter.